 - High-risk or Intermediate-2 risk MF as defined by the International Prognostic Scoring System IPSS; Appendix 13.6; or intermediate-I risk MF IPSS associated with symptomatic splenomegalyhepatomegaly andor unresponsive to available therapy. 